These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37679656)

  • 21. Comparative in vitro release testing (IVRT) of acyclovir products.
    Tiffner KI; Kanfer I; Augustin T; Raml R; Raney SG; Sinner F
    Int J Pharm; 2021 Nov; 609():121186. PubMed ID: 34655706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z; Fassihi R
    AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Membranes on In Vitro Release Assessment: a Case Study Using Dexamethasone.
    Mekjaruskul C; Beringhs AO; Luo WC; Xu Q; Halquist M; Qin B; Wang Y; Lu X
    AAPS PharmSciTech; 2021 Jan; 22(1):42. PubMed ID: 33426616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing Drug Release from Manipulated Abuse Deterrent Formulations.
    Feng X; Zidan A; Kamal NS; Xu X; Sun D; Walenga R; Boyce H; Cruz CN; Ashraf M
    AAPS PharmSciTech; 2020 Jan; 21(2):40. PubMed ID: 31897805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of Concentration on Release and Permeation Process of Model Peptide Substance-Corticotropin-From Semisolid Formulations.
    Siemiradzka W; Dolińska B; Ryszka F
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32549368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling and comparison of release profiles: Effect of the dissolution method.
    Cascone S
    Eur J Pharm Sci; 2017 Aug; 106():352-361. PubMed ID: 28627469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations.
    Le Merdy M; Spires J; Lukacova V; Tan ML; Babiskin A; Xu X; Zhao L; Bolger MB
    Pharm Res; 2020 Nov; 37(12):245. PubMed ID: 33215336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and Study of Semi-Solid Preparations Containing the Model Substance Corticotropin (ACTH): Convenience Application in Neurodegenerative Diseases.
    Siemiradzka W; Dolińska B; Ryszka F
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32316183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel USP apparatus 4 based release testing method for dispersed systems.
    Bhardwaj U; Burgess DJ
    Int J Pharm; 2010 Mar; 388(1-2):287-94. PubMed ID: 20083176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of gelatin-acacia coacervate containing benzocaine in topical formulations.
    Ichwan AM; Karimi M; Dash AK
    J Pharm Sci; 1999 Aug; 88(8):763-6. PubMed ID: 10430539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel adapter method for in vitro release testing of in situ forming implants.
    Wang X; Bao Q; Suh MS; Kastellorizios M; Wang R; Burgess DJ
    Int J Pharm; 2022 Jun; 621():121777. PubMed ID: 35489601
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Medina-López R; Guillén-Moedano S; Hurtado M
    ADMET DMPK; 2020; 8(4):411-423. PubMed ID: 35300193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Manufacturing Conditions on Pharmaceutical Properties of Petrolatum Ointment-Distribution of Hydrocarbon.
    Ashizuka Y; Otoguro S; Horisawa E
    Chem Pharm Bull (Tokyo); 2021; 69(4):352-359. PubMed ID: 33790080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New Approach for the Application of USP Apparatus 3 in Dissolution Tests: Case Studies of Three Antihypertensive Immediate-Release Tablets.
    Espíndola B; Bortolon FF; Pinto JMO; Pezzini BR; Stulzer HK
    AAPS PharmSciTech; 2018 Oct; 19(7):2866-2874. PubMed ID: 29934804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in in-vitro bioequivalence testing methods for complex ophthalmic generic products.
    Renukuntla J; Palakurthi SS; Bolla PK; Clark BA; Boddu SHS; Manda P; Sockwell S; Charbe NB; Palakurthi S
    Int J Pharm; 2022 Nov; 627():122209. PubMed ID: 36162609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive Drug Release Modeling Across Dissolution Apparatuses I and II using Computational Fluid Dynamics.
    Kubinski AM; Shivkumar G; Georgi RA; George S; Reynolds J; Sosa RD; Ju TR
    J Pharm Sci; 2023 Mar; 112(3):808-819. PubMed ID: 36336104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development in release testing of topical dosage forms: use of the Enhancer Cell with automated sampling.
    Rege PR; Vilivalam VD; Collins CC
    J Pharm Biomed Anal; 1998 Sep; 17(8):1226-33. PubMed ID: 9800641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the hanson microette and the Van Kel apparatus for in vitro release testing of topical semisolid formulations.
    Rapedius M; Blanchard J
    Pharm Res; 2001 Oct; 18(10):1440-7. PubMed ID: 11697470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissolution testing of modified release products with biorelevant media: An OrBiTo ring study using the USP apparatus III and IV.
    Reppas C; Vrettos NN; Dressman J; Andreas CJ; Miyaji Y; Brown J; Etherson K; Hanley S; Karkossa F; Karlsson E; Klein S; Maier GM; McAllister M; Mistry N; Rosenblatt K; Schäfer KJ; Smith KL; Tomaszewska I; Williams J; Winge F; Vertzoni M
    Eur J Pharm Biopharm; 2020 Nov; 156():40-49. PubMed ID: 32882421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the usefulness of compendial setups and tiny-TIM system in evaluating the in vivo performance of oral drug products with various release profiles in the fasted state: Case example sodium salt of A6197.
    Schilderink R; Protopappa M; Fleth-James J; Vertzoni M; Schaefer K; Havenaar R; Kulla I; Metzger M; Reppas C
    Eur J Pharm Biopharm; 2020 Apr; 149():154-162. PubMed ID: 32057905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.